CIK 0001635077 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aclarion, Inc.
Sign in to watch- Ticker
- ACON
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324725
- Phone
- 833 275 2266
- Business address
- 8181 ARISTA PLACE, STE 100, BROOMFIELD, CO, 80021
- Former names
- Nocimed, Inc.
Securities
- ACON Common Stock Nasdaq
- ACONW Warrant Nasdaq
- Open-market buys, last 90 days
- $15,990
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$15,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-21 | Wesemann William Director | Purchase | +11,000 | $4.35 | $48K | 52,736 |
| 2022-04-21 | Wesemann William Director | Purchase · Warrants for Common Stock (right to buy) | +11,000 | 21,040 | ||
| 2022-04-21 | Ness Brent Chief Executive Officer | Purchase | +1,000 | $4.35 | $4K | 1,000 |
| 2022-04-21 | Ness Brent Chief Executive Officer | Purchase · Warrants for Common Stock (right to buy) | +1,000 | 342,365 | ||
| 2022-04-21 | Neal David K Director | Purchase | +34,400 | $4.35 | $150K | 34,400 |
| 2022-04-21 | Neal David K Director | Purchase · Warrants for Common Stock (right to buy) | +34,400 | 104,681 |
Page 3 of 3 · 46 trades